This is the authors' abstract. We don't add key points for this paper.
The most distinguishing feature of neurons is their capacity for regenerative electrical activity. This activity imposes a significant mitochondrial burden, especially in neurons that are autonomously active, have broad action potentials, and exhibit prominent Ca(2+) entry. Many of the genetic mutations and toxins associated with Parkinson's disease compromise mitochondrial function, providing a mechanistic explanation for the pattern of neuronal pathology in this disease. Because much of the neuronal mitochondrial burden can be traced to L-type voltage-dependent channels (channels for which there are brain-penetrant antagonists approved for human use), a neuroprotective strategy to reduce this burden is available.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Surmeier et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: